Connect with us

Business

Why the Dimerix (ASX:DXB) share price is rocketing higher

Published

on

The Dimerix Ltd (ASX: DXB) share price has shot 6% higher to start the day after an update from the drug discovery company.

Why is the Dimerix share price surging higher?

Dimerix provided an update on its Phase 3 ACE2 renin angiotensin system (RAS) modulation study domain in Europe. The first 24 patients have been recruited into the study in patients with COVID-19 pneumonia, which incorporates DMX-200. DMX-200 is Dimerix’s chemokine receptor (CCR2) blocker that has been included in the global COVID-19 trial. 

The Dimerix share price has rocketed higher on the news with 22 patients from the Netherlands and 2 in the UK. Patients receive one of three randomly assigned interventions or a control as part of the study.

It comes as…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Woman claims she destroyed $33m winning lotto ticket in laundry – Yahoo News Australia
Article feature image
2 high-quality ASX 200 shares to buy – The Motley Fool Australia